Convalescent Plasma in a Patient with Protracted COVID-19 and Secondary Hypogammaglobulinemia Due to Chronic Lymphocytic Leukemia: Buying Time to Develop Immunity?
It is not exactly clear yet which type of immune response prevails to accomplish viral clearance in coronavirus disease 2019 (COVID-19). Studying a patient with chronic lymphocytic leukemia and hypogammaglobulinemia who suffered from COVID-19 provided insight in the immunological responses after tre...
Main Authors: | Jaap L. J. Hanssen, Johan Stienstra, Stefan A. Boers, Cilia R. Pothast, Hans L. Zaaijer, Jennifer M. Tjon, Mirjam H. M. Heemskerk, Mariet C. W. Feltkamp, Sandra M. Arend |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Infectious Disease Reports |
Subjects: | |
Online Access: | https://www.mdpi.com/2036-7449/13/4/77 |
Similar Items
-
Comparing SARS-CoV-2 neutralizing antibody levels in convalescent unvaccinated, convalescent vaccinated, and naive vaccinated subjects
by: Latha Dulipsingh, et al.
Published: (2023-06-01) -
Korean version of the convalescence and recovery evaluation: translation and linguistic validation
by: Hyeong Dong Yuk, et al.
Published: (2020-12-01) -
Immunoglobulins or convalescent plasma to tackle COVID-19: buying time to save lives – current situation and perspectives
by: Adriana Tamburello, et al.
Published: (2020-04-01) -
The effect of convalescent plasma on the treatment of COVID-19 patients in Ardabil, Iran
by: Effat Iranijam, et al.
Published: (2022-01-01) -
Convalescent plasma therapy in COVID-19
by: Ayse Uysal, et al.
Published: (2022-06-01)